遺伝子検査の世界市場:インサイト、市場機会、市場シェア、市場予測

◆英語タイトル:Global Genetic Testing Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022
◆商品コード:OCCAM60705
◆発行会社(調査会社):Occams Research
◆発行日:2016年5月
◆ページ数:140
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single UserUSD3,900 ⇒換算¥432,900見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD6,900 ⇒換算¥765,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はOccams Research社の日本における正規販売代理店です。Occams Research社の概要及び新刊レポートはこちらでご確認いただけます。
本調査レポートでは、世界の遺伝子検査市場について調査・分析し、市場インサイト、市場機会、市場シェア、市場規模予測などを含め、以下の構成でお届けいたします。
・遺伝子検査の世界市場:イントロダクション
・遺伝子検査の世界市場:市場概観
・遺伝子検査の世界市場:市場動向(促進要因、阻害要因、市場機会)
・遺伝子検査の世界市場:セグメント別市場分析
・遺伝子検査の世界市場:主要地域別市場分析
・遺伝子検査の世界市場:関連企業分析
【レポートの概要】

Genetic testing is a type of medical tests that identifies changes in chromosomes, proteins or in genes. The results of this type of tests confirms the genetic issues if any in patients. Genetic testing represents the most rapidly expanding segment in the molecular diagnostics market globally. Growing incidence of genetic diseases opens up new opportunities for genetic testing. The conversion of genetic testing from being a service-driven to a product-driven market is expected to provide a thrust to the diagnostic companies for the expansion of their business globally. The market for screening the Diagnostic, newborns, rare and fatal disorders, and predicting the probability of occurrence of diseases is likely to expand. Mainly, genetic tests to screen the newborns are expected to expand immensely over the coming years. Genetic testing is a sophisticated and typical form of medical testing to identify smallest changes in genes, proteins or in chromosomes that are associated with problematic diseases. The positivity or negativity of such tests can confirm suspected genetic condition and helps the doctors, physician with greater precision towards treating in genetic disorder.
Genetic testing is a bit expensive and cannot afford by all of the people. Due to time and knowledge required in the testing of rare diseases genetic testing is expensive procedure and cannot be adopted by normal peoples. This is the major drawback and it affects the growth and affects the market globally.

Genetic testing market growth is growing by increasing adoption in oncology applications, growing public awareness and demand for customized medicine. There is an increase in life expectancy and a growing aging population. There is rise in growth of chronic diseases and an increasing incidence of cancer etc. and these factors are boosting growth of the genetic testing market. The major role of genetics in diseases and health is now understood. This new combined knowledge with lower pricing is taking genetic testing market to the next level. The genetic testing market is growing rapidly in breadth and in the volume of tests creating new life in the industry.

Consumer demand for effective and safe way to treat diseases is rising. The scenario is beneficial for demand for genetic testing, the important role played by this tests to identifies the problematic chromosome, and genes are way too high. The genetic tests is very much helpful in identifying Cancer, cystic fibrosis, Alzheimer’s. Molecular diagnostic involves analysis of DNA and RNA, this drives the increasing awareness of human genome. Faster screening, technological advancement, accurate detection and genetic testing. The major reason also includes favorable regulation environment, adoption of genetic testing by physicians in daily routine etc. Technological advancement in the field of genetic testing drives the physicians to determine the patients’ health at different levels of treatment by diagnostic procedures.
With advancement in DNA analysis, the scope of genetic testing widens up in different areas, mainly in pharmacogenomics, predictive testing, and prenatal testing and so on. The early detection of genetic disorder reduces mortality rates. Genetic testing also enhances the early detection of breast cancer.

The global genetic testing market is segmented into type, application and regional outlook. In type market is divided into carrier testing, diagnostic testing, newborn screening and prenatal testing diagnostic testing is majorly used in the area to identify problematic chromosomes, genes and other proteins. In application market is segmented into cancer genetic testing, prenatal genetic testing, pharmacogenomics, and predisposition testing. Cancer genetic testing is having the largest market share in this segment. Cancer is very chronic disease and it took millions of lives per year. Genetic testing identifies the problematic alteration in the body. This save many lives of the people.

In regional outlook market is divided into North America, Asia pacific, Europe and rest of the world. U.S is the global leader in genetic testing market, the major reason in growth of this region is due to technological advancement in the field of genetic engineering, increasing prevalence of genetic diseases and high quality of infrastructure. Asia Pacific is the fastest growing market due to increase in number of ageing population, increase in problematic diseases, and advancement in medical field. China is the fastest growing country in this region. Rest of the world is also growing in this market, major countries like Dubai and South Africa. Europe is also sharing the market due to ageing population and increased disposal income of the people.

Major players like Roche Diagnostics Ltd., Pacific Bioscience Of California, Inc., Oxford Biodynamics, Myriad Genetics, Inc., Luminex Corporation, Laboratory Corporation Of America Holdings, Qiagen N.V etc. are using merger and acquisition, new products developments to expand.

【レポートの目次】

1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW
2.1. MARKET DEFINITION AND SCOPE
2.2. KEY FINDINGS
2.3. PARAMETRIC ANALYSIS
2.3.1. INCREASING AGEING POPULATION
2.3.2. R&D IN GENETIC FIELD
2.4. KEY MARKET INSIGHTS
2.4.1. TOP 3 EMERGING COUNTRIES
2.4.2. TOP 3 REVENUE GENERATING SEGMENTS
2.4.3. TOP GROWING MARKETS AND EMERGING TRENDS
2.4.4. TOP 3 GEOGRAPHY
2.5. COMPETITIVE LANDSCAPE
2.5.1. MARKET SHARE ANALYSIS
2.5.2. TOP WINNING STRATEGIES
2.5.3. CASE STUDIES: TOP COMPETITIVE MOVES
2.6. PORTER’S FIVE FORCE MODEL
2.6.1. THREAT OF NEW ENTRANTS
2.6.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
2.6.3. BARGAINING POWER OF BUYER
2.6.4. BARGAINING POWER OF SUPPLIER
2.6.5. INTENSITY OF COMPETITIVE RIVALRY
2.7. KEY BUYING CRITERIA
2.8. STRATEGIC RECOMMENDATION
2.9. STRATEGIC CONCLUSIONS

3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. EARLY CONFIRMATION OF GENETIC DISORDER
3.1.2. MINIMAL PROCEDURE RISK
3.1.3. INCREASE OF PIPELINE GENETIC TESTS
3.2. MARKET RESTRAINTS
3.2.1. FALSE POSITIVE AND FALSE NEGATIVE RESULTS
3.2.2. POTENTIAL ADVERSE PERSONAL OR SOCIETAL CONSEQUENCES
3.3. MARKET OPPORTUNITIES
3.3.1. GENETIC COUNCELLING
3.3.2. EXPANSION OF BREAST CANCER GENES TESTING MARKET
3.3.3. NEW AND IMPROVED TECHNOLOGY
3.4. MARKET CHALLENGES
3.4.1. HIGH PRICES OF TESTS
3.4.2. RAW MATERIAL AND PRODUCTION COST IS HIGH
3.5. PARENT MARKET
3.6. COMPETITORS MARKET
3.7. ALTERNATIVE MARKET

4. MARKET SEGMENTATION
4.1. BY TYPE
4.1.1. GLOBAL CARRIER TESTING MARKET 2014-2022 ($MILLION)
4.1.2. GLOBAL DIAGNOSTIC TESTING MARKET 2014-2022 ($MILLION)
4.1.3. GLOBAL NEWBORN SCREENING MARKET 2014-2022 ($MILLION)
4.1.4. GLOBAL PRENATAL TESTING MARKET 2014-2022 ($MILLION)
4.2. BY APPLICATION
4.2.1. GLOBAL CANCER GENETIC TESTING MARKET 2014-2022($MILLION)
4.2.2. GLOBAL PRENATAL GENETIC TESTING MARKET 2014-2022($MILLION)
4.2.3. GLOBAL PHARMACOGENOMICS MARKET 2014-2022($MILLION)
4.2.4. GLOBAL PREDISPOSITION MARKET 2014-2022($MILLION)

5. GEOGRAPHICAL ANALYSIS
5.1. NORTH AMERICA GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
5.1.1. UNITED STATES (U.S.) GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
5.1.2. CANADA GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
5.2. EUROPE GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
5.2.1. UNITED KINGDOM (UK) GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
5.2.2. FRANCE GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
5.2.3. GERMANY GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
5.2.4. SPAIN GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
5.2.5. ITALY GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
5.2.6. ROE GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
5.3. ASIA PACIFIC GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
5.3.1. INDIA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
5.3.2. CHINA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
5.3.3. JAPAN REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
5.3.4. KOREA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
5.3.5. ROAPAC REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
5.4. REST OF THE WORLD GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
5.4.1. LATIN AMERICA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
5.4.2. MENA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
5.4.3. AFRICA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)

6. COMPANY PROFILING: – (OVER, SCOT ANALYSIS, STRATEGIC REVIEW)
1. CEPHEID
2. DAAN DIAGNOSTICS LTD.
3. GENENTECH, INC.
4. GENOMICTREE, INC.
5. HTG MOLECULAR DIAGNOSTICS, INC.
6. ILLUMINA, INC
7. INTEGRAGEN S.A
8. LABORATORY CORPORATION OF AMERICA HOLDINGS
9. LUMINEX CORPORATION
10. MOLECULARMD, CORP.
11. MYRIAD GENETICS, INC.
12. NATERA, INC.
13. OXFORD BIODYNAMICS LIMITED
14. PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
15. PERKINELMER, INC.
16. QIAGEN N.V.
17. ROCHE DIAGNOSTICS LIMITED

LIST OF TABLES
1. GLOBAL CARRIER TESTING MARKET 2014-2022 ($MILLION)
2. GLOBAL DIAGNOSTIC TESTING MARKET 2014-2022 ($MILLION)
3. GLOBAL NEWBORN SCREENING MARKET 2014-2022 ($MILLION)
4. GLOBAL PRENATAL TESTING 2014-2022 ($MILLION)
5. GLOBAL CANCER GENETIC TESTING MARKET 2014-2022($MILLION)
6. GLOBAL PRENATAL GENETIC TESTING MARKET 2014-2022($MILLION)
7. GLOBAL PHARMACOGENOMICS MARKET 2014-2022($MILLION)
8. GLOBAL PREDISPOSITION MARKET 2014-2022($MILLION)
9. NORTH AMERICA GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
10. EUROPE GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
11. ASIA PACIFIC GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
12. REST OF THE WORLD GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)

LIST OF FIGURES
1. GLOBAL CARRIER TESTING MARKET 2014-2022 ($MILLION)
2. GLOBAL DIAGNOSTIC TESTING MARKET 2014-2022 ($MILLION)
3. GLOBAL NEWBORN SCREENING MARKET 2014-2022 ($MILLION)
4. GLOBAL PRENATAL TESTING 2014-2022 ($MILLION)
5. GLOBAL CANCER GENETIC TESTING MARKET 2014-2022($MILLION)
6. GLOBAL PRENATAL GENETIC TESTING MARKET 2014-2022($MILLION)
7. GLOBAL PHARMACOGENOMICS MARKET 2014-2022($MILLION)
8. GLOBAL PREDISPOSITION MARKET 2014-2022($MILLION)
9. NORTH AMERICA GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
10. UNITED STATES (U.S.) GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
11. CANADA GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
12. EUROPE GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
13. UNITED KINGDOM (UK) GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
14. FRANCE GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
15. GERMANY GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
16. SPAIN GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
17. ITALY GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
18. ROE GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
19. ASIA PACIFIC GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
20. INDIA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
21. CHINA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
22. JAPAN REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
23. KOREA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
24. ROAPAC REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
25. REST OF THE WORLD GLOBAL GENETIC TESTING MARKET 2014-2022 ($MILLION)
26. LATIN AMERICA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
27. MENA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)
28. AFRICA REVENUE MANAGEMENT MARKET 2014-2022 ($MILLION)



【レポートのキーワード】

遺伝子検査、キャリア検査、診断検査、新生児スクリーニング

★調査レポート[遺伝子検査の世界市場:インサイト、市場機会、市場シェア、市場予測]販売に関する免責事項
★調査レポート[遺伝子検査の世界市場:インサイト、市場機会、市場シェア、市場予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆